DEPATUXIZUMAB MAFODOTIN
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | BINDING AGENT | Epidermal growth factor receptor erbB1 binding agent | no | 3 | 3 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | BINDING AGENT | Epidermal growth factor receptor erbB1 binding agent | no | 3 | 3 |